Credit: Rady Children’s Hospital-San Diego
A test run of the personalized drug screen was completed using a brain tumor from an 8-year-old boy newly diagnosed with metastatic medulloblastoma. An information package about his tumor, including subtype and drug screening results, identified several drugs that may be effective for his tumor and was reviewed by doctors on a molecular tumor board—demonstrating the feasibility of the method to guide patient care.